parkin counteracts symptoms in a Drosophila model of Parkinson's disease

[1]  M. Ruberg,et al.  The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates , 2003, Neurobiology of Disease.

[2]  P. Lockhart,et al.  RING finger 1 mutations in Parkin produce altered localization of the protein. , 2003, Human molecular genetics.

[3]  K. Park,et al.  Genomic organization and expression of parkin in Drosophila melanogaster , 2003, Experimental & Molecular Medicine.

[4]  Clemens R Scherzer,et al.  Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease. , 2003, Human molecular genetics.

[5]  Clay W Scott,et al.  Parkin suppresses wild-type α-synuclein-induced toxicity in SHSY-5Y cells , 2003 .

[6]  David W. Miller,et al.  Co‐ordinate transcriptional regulation of dopamine synthesis genes by α‐synuclein in human neuroblastoma cell lines , 2003, Journal of neurochemistry.

[7]  Isao Nishimura,et al.  Parkin Suppresses Dopaminergic Neuron-Selective Neurotoxicity Induced by Pael-R in Drosophila , 2003, Neuron.

[8]  J. C. Greene,et al.  Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  N. Hattori,et al.  Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin‐like domain , 2003, EMBO reports.

[10]  J. Arriza,et al.  Parkin suppresses wild-type alpha-synuclein-induced toxicity in SHSY-5Y cells. , 2003, Biochemical and biophysical research communications.

[11]  G. Rubin,et al.  A Drosophila full-length cDNA resource , 2002, Genome Biology.

[12]  P. Lockhart,et al.  Parkin Protects against the Toxicity Associated with Mutant α-Synuclein Proteasome Dysfunction Selectively Affects Catecholaminergic Neurons , 2002, Neuron.

[13]  Ignacio Marín,et al.  Comparative genomics of the RBR family, including the Parkinson's disease-related gene parkin and the genes of the ariadne subfamily. , 2002, Molecular biology and evolution.

[14]  P. Auluck,et al.  Pharmacological prevention of Parkinson disease in Drosophila , 2002, Nature Medicine.

[15]  Jian Wang,et al.  The Genome Sequence of the Malaria Mosquito Anopheles gambiae , 2002, Science.

[16]  P. Lansbury,et al.  Genetics of Parkinson's disease and biochemical studies of implicated gene products. , 2002, Current opinion in genetics & development.

[17]  Peter T Lansbury,et al.  Genetics of Parkinson's disease and biochemical studies of implicated gene products. , 2002, Current opinion in cell biology.

[18]  M. Zigmond,et al.  A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis , 2002, The Journal of Neuroscience.

[19]  J. Trojanowski,et al.  Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. , 2002, Science.

[20]  M. Zigmond,et al.  A role for alpha-synuclein in the regulation of dopamine biosynthesis. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[21]  R. Pendleton,et al.  Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. , 2002, The Journal of pharmacology and experimental therapeutics.

[22]  John Q. Trojanowski,et al.  Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease , 2001, Science.

[23]  C. Ross,et al.  Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease , 2001, Nature Medicine.

[24]  V. Lee,et al.  Parkin and the Molecular Pathways of Parkinson's Disease , 2001, Neuron.

[25]  N. Hattori,et al.  Parkin and Parkinson's disease , 2001, Current opinion in neurology.

[26]  N. Hattori,et al.  An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of Parkin , 2001, Cell.

[27]  Nobutaka Hattori,et al.  Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease , 2001, Science.

[28]  N. Hattori,et al.  Parkin is linked to the ubiquitin pathway , 2001, Journal of Molecular Medicine.

[29]  C. Pickart,et al.  Mechanisms underlying ubiquitination. , 2001, Annual review of biochemistry.

[30]  T. Dawson,et al.  Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Y. Imai,et al.  Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity* , 2000, The Journal of Biological Chemistry.

[32]  U. Leimer,et al.  Does failure of parkin-mediated ubiquitination cause juvenile parkinsonism? , 2000, Trends in biochemical sciences.

[33]  Hitoshi Takahashi,et al.  An autopsy case of autosomal‐recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene , 2000, Movement disorders : official journal of the Movement Disorder Society.

[34]  E. Tolosa,et al.  A new mutation in the parkin gene in a patient with atypical autosomal recessive juvenile parkinsonism , 2000, Neuroscience Letters.

[35]  Shinsei Minoshima,et al.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.

[36]  T. Dawson.  New Animal Models for Parkinson's Disease , 2000, Cell.

[37]  W. Bender,et al.  A Drosophila model of Parkinson's disease , 2000, Nature.

[38]  P. Lansbury,et al.  Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. , 2000, Biochemistry.

[39]  J. Hirsh,et al.  Ectopic G-protein expression in dopamine and serotonin neurons blocks cocaine sensitization in Drosophila melanogaster , 2000, Current Biology.

[40]  P. Lansbury,et al.  Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Freemont.  Ubiquitination: RING for destruction? , 2000, Current Biology.

[42]  S. Blumen,et al.  Autosomal-recessive juvenile parkinsonism in a Jewish Yemenite kindred: mutation of Parkin gene. , 1999, Neurology.

[43]  N. Wood,et al.  The genetics of Parkinson's disease. , 1999, Current opinion in neurology.

[44]  P. Bork,et al.  A novel transactivation domain in parkin. , 1999, Trends in biochemical sciences.

[45]  Peter T. Lansbury,et al.  Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.

[46]  T. Kondo,et al.  Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q , 1998, Neurology.

[47]  David F. Clayton,et al.  The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.

[48]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[49]  Etsuko N. Moriyama,et al.  Codon Usage Bias and tRNA Abundance in Drosophila , 1997, Journal of Molecular Evolution.

[50]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[51]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[52]  Gapped BLAST and PSI-BLAST: A new , 1997 .

[53]  M. Polymeropoulos,et al.  Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23 , 1996, Science.

[54]  M. Freeman,et al.  Reiterative Use of the EGF Receptor Triggers Differentiation of All Cell Types in the Drosophila Eye , 1996, Cell.

[55]  A. Ishikawa,et al.  Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism , 1996, Neurology.

[56]  É. Bourg,et al.  Hypergravity and Aging in Drosophila melanogaster , 1996 .

[57]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[58]  Michel Goedert,et al.  Identification of two distinct synucleins from human brain , 1994, FEBS letters.

[59]  N. Perrimon,et al.  Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. , 1993, Development.

[60]  É. Le Bourg,et al.  Hypergravity and aging in Drosophila melanogaster. 4. Climbing activity. , 1992, Gerontology.

[61]  A. Hilliker,et al.  Phenotypic consequences of copper-zinc superoxide dismutase overexpression in Drosophila melanogaster. , 1990, Genome.

[62]  D. Cavener,et al.  Comparison of the consensus sequence flanking translational start sites in Drosophila and vertebrates. , 1987, Nucleic acids research.

[63]  H. Atlan,et al.  Effects of temperature on the life span, vitality and fine structure of Drosophila melanogaster , 1976, Mechanisms of Ageing and Development.

[64]  W. Gowers,et al.  A Manual of Diseases of the Nervous System , 1887, Edinburgh Medical Journal.

[65]  P. James.  An Essay on the Shaking Palsy , 1817, The Medico-Chirurgical Journal and Review.

[66]  J. Parkinson.  An Essay on the Shaking Palsy , 2002 .